Close menu

SURE

Sunderland Repository records the research produced by the University of Sunderland including practice-based research and theses.

GJA4/Connexin 37 Mutations Correlate with Secondary Lymphedema Following Surgery in Breast Cancer Patients

Hadizadeh, Mahrooyeh, Mohaddes Ardebili, Seiied, Salehi, Mansoor, Young, Chris, Mokarian, Fariborz, McClellan, James, Xu, Qin, Kazemi, Mohammad, Moazam, Elham, Mahaki, Behzad and Ashrafian Bonab, Maziar (2018) GJA4/Connexin 37 Mutations Correlate with Secondary Lymphedema Following Surgery in Breast Cancer Patients. Biomedicines, 6 (1). p. 23. ISSN 2227-9059

Item Type: Article

Abstract

Lymphedema is a condition resulting from mutations in various genes essential for lymphatic development and function, which leads to obstruction of the lymphatic system. Secondary lymphedema is a progressive and incurable condition, most often manifesting after surgery for breast cancer. Although its causation appears complex, various lines of evidence indicate that genetic predisposition may play a role. Previous studies show that mutations in connexin 47 are associated with secondary lymphedema. We have tested the hypothesis that connexin 37 gene mutations in humans are associated with secondary lymphedema following breast cancer surgery. A total of 2211 breast cancer patients were screened and tested for reference single nucleotide polymorphisms (SNPs) of the GJA4 gene (gap junction protein alpha 4 gene). The results presented in this paper indicate that two SNPs in the 3’ UTR (the three prime untranslated region) of the GJA4 gene are associated with an increased risk of secondary lymphedema in patients undergoing breast cancer treatment. Our results provide evidence of a novel genetic biomarker for assessing the predisposition to secondary lymphedema in human breast cancer patients. Testing for the condition-associated alleles described here could assist and inform treatment and post-operative care plans of breast cancer patients, with potentially positive outcomes for the management of disease progression.

[img]
Preview
PDF
biomedicines-06-00023.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

More Information

Depositing User: Leah Maughan

Identifiers

Item ID: 12939
Identification Number: https://doi.org/10.3390/biomedicines6010023
ISSN: 2227-9059
URI: http://sure.sunderland.ac.uk/id/eprint/12939
Official URL: http://dx.doi.org/10.3390/biomedicines6010023

Users with ORCIDS

ORCID for Maziar Ashrafian Bonab: ORCID iD orcid.org/0000-0002-9833-7976

Catalogue record

Date Deposited: 04 Jan 2021 17:03
Last Modified: 04 Jan 2021 17:15

Contributors

Author: Maziar Ashrafian Bonab ORCID iD
Author: Mahrooyeh Hadizadeh
Author: Seiied Mohaddes Ardebili
Author: Mansoor Salehi
Author: Chris Young
Author: Fariborz Mokarian
Author: James McClellan
Author: Qin Xu
Author: Mohammad Kazemi
Author: Elham Moazam
Author: Behzad Mahaki

University Divisions

Faculty of Health Sciences and Wellbeing > School of Nursing and Health Sciences

Actions (login required)

View Item (Repository Staff Only) View Item (Repository Staff Only)